ARF1 and prostate carcinoma: We have previously studied Arf1 inhibitors and have shown that LM11 could inhibit cell invasion and suppressed metastasis in breast cancer [18], as well as Exo2 could inhibit cell migration and invasion in prostate cancer [11].